The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.Additionally, a review of the complaint history identified no similar complaints from the lot.All available information was investigated, and a cause for the reported slda cannot be determined.Mitral valve insufficiency/ regurgitation appears to be due to the slda.Mitral regurgitation is listed in the instructions for use (ifu) as a known possible complication associated with mitraclip procedures.Unexpected medical intervention and hospitalization were a result of case-specific circumstances.There is no indication of a product issue with respect to manufacture, design or labeling.
|
It was reported that on (b)(6) 2024, a mitraclip procedure was performed to treat a functional mitral regurgitation (mr) with grade of 4 and restricted posterior leaflet.One clip was implanted, reducing mr to grade <1.On (b)(6) 2024, the clip was observed to detach from the posterior leaflet (single leaflet device attachment (slda)).Mr increased to grade 3.On (b)(6) 2024, the patient underwent additional mitraclip procedure to stabilize the slda clip and reduce recurrent mr of grade 3.Two clips (xt and nt) were implanted on the lateral side of the slda clip, reducing mr to grade 1.There was no clinically significant delay in the procedure and no adverse patient effects.
|